Radiochemotherapy plus Bip inhibitor and IR-induced immunity efficiently extended survival of glioma bearing mice (Fig. 7b), and reduced tumor sizes after GL261s rechallenge (Fig. 7c). This evidence concerns the gene HSPA5 and neoplasm.